Q1 2018 13F Holders as of 31 Mar 2018
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
29,067,614
-
Total 13F shares
-
3,076,255
-
Share change
-
-160,094
-
Total reported value
-
$31,040,000
-
Price per share
-
$10.09
-
Number of holders
-
12
-
Value change
-
-$1,629,988
-
Number of buys
-
4
-
Number of sells
-
4
Institutional Holders of Krystal Biotech, Inc. - COMMON STOCK (KRYS) as of Q1 2018
As of 31 Mar 2018,
Krystal Biotech, Inc. - COMMON STOCK (KRYS) was held by
12 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
3,076,255 shares.
The largest 10 holders included
FMR LLC, RA CAPITAL MANAGEMENT, LLC, Knoll Capital Management, LP, HIGHBRIDGE CAPITAL MANAGEMENT LLC, Tourbillon Capital Partners, L.P., BAKER BROS. ADVISORS LP, Artal Group S.A., VANGUARD GROUP INC, MILLENNIUM MANAGEMENT LLC, and BlackRock Inc..
This page lists
12
institutional shareholders reporting positions in this security
for the Q1 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.